Author: John Laub

John Laub has been President, Chief Executive Officer and Chairman of our Board since the inception of WUND Healing Biopharmacueticals in May 2016. With over 30 years business experience and 15 years in the biotechnology field, Mr. Laub brings leadership and deep industry knowledge to our executive team. Since 2008, Mr. Laub has served as President of the Nevada Biotechnology & Health Sciences Consortium, a non-profit membership organization promoting biotechnology, health sciences and whole-plant medicine. He has also served as the representative from Nevada for the national Biotechnology Innovation Organization (BIO) since 2008. From June 2010 to September 2019, Mr. Laub was the Chairman of the Board of Advisors for the University of Nevada, Las Vegas College of Sciences. Previously, from June 2006 to March 2016, Mr. Laub served as Chief Executive Officer of the Regenerative Medicine Organization. Mr. Laub received a B.S. in Accounting from Oregon State University and has been a Certified Public Accountant in good standing with the Nevada State Board of Accountancy since 1992.

OPINION: Proposal to Reduce the Cost of Prescription Drugs Is Misguided

March 15, 2024 11:11 amMarch 16, 2024 12:54 pm

Once again, a misguided proposal aimed to reduce the cost of prescription drugs, would not only fail to reduce prices, but would erode an Act of Congress enacted in 1980. The United States has played a pivotal role in spearheading drug discovery efforts, which have been instrumental in achieving remarkable...

Expanding The TRIPS Waiver Could Hamper Medical Innovation

June 7, 2023 11:22 am

There’s an important political, philosophical, and policy battle brewing on the front lines of American health care, and my guess is very few Americans are tuned in to it. That’s understandable, considering the complexity of the issue and the number of various government agencies, advocates and organizations weighing in. This battle boils...